InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding InMed Pharmaceuticals Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 227.0K | 319.3K | +92.3K (+40.6%) |
| Value | $240.7K | $206.0K | −$34.6K (−14.4%) |
New holders (4)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 46,973 | $30.3K | 0.00% |
| Virtu Financial LLC | 19,980 | $13.0K | 0.00% |
| Two Sigma Securities, LLC | 18,718 | $12.1K | 0.00% |
| Private Wealth Management Group, LLC | 5,000 | $3.23K | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 12,753 | $13.5K |
| Jane Street Group, LLC | 11,978 | $12.7K |